BlackRock Advisors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
GE
FLAM
NCGI
GIM
CRC
DCM
BFA
BIT
BlackRock Advisors's NEO Position: Q4 2016 in Review
BlackRock Advisors reduced its NeoGenomics (NEO) stake by 1.5% in Q4 2016, selling an estimated $3.75K and leaving 28,528 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #2616.
BlackRock Advisors first reported a position in NEO in Q2 2013 and has held it in 13 quarters since. 143 funds tracked by Wall St. Rank hold NEO as of Q4 2016.
- BlackRock Advisors held 28,528 shares of NeoGenomics worth $244K as of Q4 2016.
- BlackRock Advisors sold 438 NeoGenomics shares in Q4 2016, an estimated $3.75K.
- NeoGenomics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2616 holding.
- BlackRock Advisors first reported a position in NeoGenomics in Q2 2013 and has held it in 13 quarters since.
- 143 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2016.
Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.